Prospects for targeting PD-1 and PD-L1 in various tumor types.
Kim JW, Eder JP. Prospects for targeting PD-1 and PD-L1 in various tumor types. Oncology 2014, 28 Suppl 3: 15-28. PMID: 25387682.Peer-Reviewed Original ResearchMechanisms of immunotherapy resistance in mCRPC: identifying the enemy on the visceral metastatic battlefield.
Kim JW, Bilusic M, Plimack ER. Mechanisms of immunotherapy resistance in mCRPC: identifying the enemy on the visceral metastatic battlefield. Oncology 2014, 28: 986-90. PMID: 25403631.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, MonoclonalBone NeoplasmsDrug Resistance, NeoplasmHumansImmunotherapyIpilimumabLiver NeoplasmsLung NeoplasmsMaleProstatic Neoplasms, Castration-ResistantViscera